Reneuron Group

ReNeuron is a leading, UK-based stem cell company. Our primary objective is the development of stem cell therapies targeting areas of significant unmet or poorly met medical need
Type
Public
HQ
Surrey Research Park, GB
Founded
1997
Size (employees)
44 (est)+34%
Reneuron Group was founded in 1997 and is headquartered in Surrey Research Park, GB

Key People at Reneuron Group

Michael Hunt

Michael Hunt

CEO
John Sinden

John Sinden

CSO

Reneuron Group Office Locations

Reneuron Group has office in Surrey Research Park
Surrey Research Park, GB

Reneuron Group Metrics

Reneuron Group Summary

Market capitalization

£73.6 m

Closing share price

£0
Reneuron Group's current market capitalization is £73.6 m.

Reneuron Group Financials

Reneuron Group's revenue is £29 k in FY, 2016 which is a 3.3% decrease from the previous period.
FY, 2014FY, 2015FY, 2016

Revenue

£22 k£30 k£29 k

Revenue growth, %

136263.6%(3.3%)

Reneuron Group Market Value History

We estimate that Reneuron Group's current employees are approximately 15% female and 85% male.

Reneuron Group Company Life

You may also be interested in